{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "regularMarketChangePercent": -0.94029504, "regularMarketPrice": 21.07, "exchange": "SHH", "shortName": "BRIGHTGENE BIO-MEDICAL TECHNOLO", "longName": "BrightGene Bio-Medical Technology Co., Ltd.", "messageBoardId": "finmb_100540669", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "cn_market", "marketState": "POSTPOST", "esgPopulated": false, "priceEpsCurrentYear": 31.44776, "sharesOutstanding": 422464992, "bookValue": 5.457, "fiftyDayAverage": 23.1928, "fiftyDayAverageChange": -2.1228008, "fiftyDayAverageChangePercent": -0.09152844, "twoHundredDayAverage": 22.1514, "twoHundredDayAverageChange": -1.0813999, "twoHundredDayAverageChangePercent": -0.04881858, "marketCap": 8901337088, "forwardPE": 25.083334, "priceToBook": 3.861096, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.3 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1573176600000, "priceHint": 2, "regularMarketChange": -0.20000076, "regularMarketTime": 1683874803, "regularMarketDayHigh": 21.58, "regularMarketDayRange": "21.03 - 21.58", "regularMarketDayLow": 21.03, "regularMarketVolume": 1761017, "regularMarketPreviousClose": 21.27, "bid": 21.09, "ask": 21.09, "fullExchangeName": "Shanghai", "financialCurrency": "CNY", "regularMarketOpen": 21.1, "averageDailyVolume3Month": 3218415, "averageDailyVolume10Day": 3573861, "fiftyTwoWeekLowChange": 3.9699993, "fiftyTwoWeekLowChangePercent": 0.2321637, "fiftyTwoWeekRange": "17.1 - 26.16", "fiftyTwoWeekHighChange": -5.09, "fiftyTwoWeekHighChangePercent": -0.19457187, "fiftyTwoWeekLow": 17.1, "fiftyTwoWeekHigh": 26.16, "earningsTimestamp": 1629889140, "earningsTimestampStart": 1651229940, "earningsTimestampEnd": 1651492800, "trailingAnnualDividendRate": 0.114, "trailingPE": 35.116665, "trailingAnnualDividendYield": 0.0053596613, "epsTrailingTwelveMonths": 0.6, "epsForward": 0.84, "epsCurrentYear": 0.67, "symbol": "688166.SS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building C25-28", "address2": "Bio-Nano Park No.218 Xinghu Road Suzhou Industrial Park", "city": "Suzhou", "zip": "215123", "country": "China", "phone": "86 512 6262 0988", "fax": "86 512 6255 1799", "website": "https://www.bright-gene.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BrightGene Bio-Medical Technology Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of medicines, and generic APIs and FDFs in China. Its product pipeline includes immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, and novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis. The company also develops Eribulin, Trabectedin, Fondaparinux, Caspofungin, and non-biological molecules; macromolecules, such as Ferumoxytol and Ferric pyrophosphate citrate; and ADC cytotoxic payloads comprising Maytansinoids, Auristatins, and Calicheamicin. It offers cardiovascular, antibacterial, ADC, oncology, antifungal, iron supplement, anti-HBV, veterinary, and immuno products. The company was founded in 2001 and is based in Suzhou, China.", "fullTimeEmployees": 1128, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jiandong  Yuan", "age": 52, "title": "Chairman & GM", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}